82 results
Page 2 of 5
8-K
EX-1.1
4r5yfyfstiux5t7nk7
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
424B5
ujev t8xdjj5
16 Feb 21
Prospectus supplement for primary offering
5:11pm
424B5
6y32kj77ejmpmq2fuw
16 Feb 21
Prospectus supplement for primary offering
6:03am
8-K
EX-1.1
j67b5gn57a62rlc4
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
8-K
EX-99.1
gl0h8pon wnhzhar
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
8-K
EX-5.1
tym805 zd
27 Mar 20
Other Events
12:53pm
424B5
5khly0nc2ng3
26 Mar 20
Prospectus supplement for primary offering
9:33pm
8-K
EX-1.1
ec1hrlxuadz pftu3pn
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-5.1
zykronr
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
424B5
z2xnosswvkh1shff71
12 Feb 20
Prospectus supplement for primary offering
9:05am